Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S. Winkler, Michael Diamond, Pavlo Gilchuk et al.|Cell|2021Cited by 392
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibodyNicole V. Johnson, Ivelin S. Georgiev, Sivakumar Periasamy et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3